Zydus Lifesciences Closes Trading Window for Q3 FY27 Results

Zydus Lifesciences Limited has announced the closure of its trading window for directors and designated persons, effective October 1, 2026. This closure will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending September 30, 2026. The specific date for the Board meeting to approve these financial results will be communicated separately. This measure is in compliance with the company's Code of Insider Trading to prevent potential misuse of unpublished price-sensitive information.